127 related articles for article (PubMed ID: 36379678)
1. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical Cancer.
Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
[TBL] [Abstract][Full Text] [Related]
2. Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study.
Alshehri MA; Asiri SA; Alzahrani A; Alazragi RS; Alqahtani LS; Alqosaibi AI; Alnamshan MM; Alam Q; Rafeeq MM
Med Oncol; 2023 Oct; 40(11):337. PubMed ID: 37864019
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.
Almasoudi HH; Hakami MA; Alhazmi AY; Makkawi M; Alasmari S; Alghamdi YS; Mashraqi MM
Med Oncol; 2023 Jul; 40(8):218. PubMed ID: 37394519
[TBL] [Abstract][Full Text] [Related]
4. Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
Almasoudi HH; Nahari MH; Alhazmi AYM; Almasabi SHA; Al-Mansour FSH; Hakami MA
PLoS One; 2023; 18(12):e0295714. PubMed ID: 38100507
[TBL] [Abstract][Full Text] [Related]
5. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX.
Chahal V; Kakkar R
J Biomol Struct Dyn; 2023; 41(12):5465-5480. PubMed ID: 35735269
[TBL] [Abstract][Full Text] [Related]
6. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and
Ahmad S; Singh V; Gautam HK; Raza K
J Biomol Struct Dyn; 2024 Mar; 42(5):2494-2511. PubMed ID: 37154501
[TBL] [Abstract][Full Text] [Related]
7. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study.
Almasoudi HH; Mashraqi MM; Alshamrani S; Alsalmi O; Alharthi AA; Gharib AF
J Biomol Struct Dyn; 2024; 42(1):11-21. PubMed ID: 37771142
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study.
Alghamdi S; Baeissa HM; Azhar Kamal M; Rafeeq MM; Al Zahrani A; Maslum AA; Hakeem IJ; Alazragi RS; Alam Q
J Biomol Struct Dyn; 2023 Aug; ():1-13. PubMed ID: 37599470
[TBL] [Abstract][Full Text] [Related]
9. Variolin B from sea sponge against lung cancer: a multitargeted molecular docking with fingerprinting and molecular dynamics simulation study.
Alsalmi O; Mashraqi MM; Alshamrani S; Almasoudi HH; Alharthi AA; Gharib AF
J Biomol Struct Dyn; 2024 Apr; 42(7):3507-3519. PubMed ID: 37855303
[TBL] [Abstract][Full Text] [Related]
10. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
Rezvani S; Ebadi A; Razzaghi-Asl N
J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
[TBL] [Abstract][Full Text] [Related]
12. Fragment-based design and MD simulations of human papilloma virus-16 E6 protein inhibitors.
Vemula V; Marudamuthu AS; Prasad S; B M S; S E M; A S; Seal P; Alagumuthu M
J Biomol Struct Dyn; 2024; 42(1):288-297. PubMed ID: 37098806
[TBL] [Abstract][Full Text] [Related]
13. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.
Roy R; Sk MF; Jonniya NA; Poddar S; Kar P
J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone 2HCl's adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach.
Hakami MA; Hazazi A; Alsulami MO; Alsaiari AA
J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38517073
[TBL] [Abstract][Full Text] [Related]
15. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
[TBL] [Abstract][Full Text] [Related]
16. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
PeerJ; 2022; 10():e14171. PubMed ID: 36389420
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
Kumari M; Subbarao N
J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
[TBL] [Abstract][Full Text] [Related]
19.
Rahman M; Khan MKA
J Biomol Struct Dyn; 2020 Apr; 38(7):2093-2103. PubMed ID: 31184285
[TBL] [Abstract][Full Text] [Related]
20. Computational investigation of phytochemicals from
Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
